Compare Mitrabara Adiperdana Tbk. (MBAP) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mitrabara Adiperdana Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Mitrabara Adiperdana Tbk. trades at Rp1,720 (market cap 2.16T, 52K 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Mitrabara Adiperdana Tbk. is far larger — about 20.7× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| MBAP | SCPI | |
|---|---|---|
Market Cap | 2.16T | 104.4B |
Volume | 52K | — |
Lot | 520 | — |
Turnover | 89M | — |
Average Price | 1,711.52 | — |
Value | 89M | — |
Indicative Equilibrium Price | 1,720 | — |
Indicative Equilibrium Volume | 1 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Mitrabara Adiperdana Tbk.
PT Mitrabara Adiperdana Tbk (the Company) was established in the Republic of Indonesia under its initial name of PT Mitrabara Adiperdana on May 29, 1992 based on the Notarial Deed No. 34 of H.A. Kadir Usman, S.H.
Read more on MBAP →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
